Allergan To Pay $13.5M To End Doctors' Botox Pricing Suit
Allergan Inc. has agreed to pay a class of doctors $13.45 million to settle allegations it inflated the price of Botox by cutting a deal to keep a competing product off...To view the full article, register now.
Already a subscriber? Click here to view full article